phase readout
saveNCT07471815: Camrelizumab Plus Risedronate and Chemotherapy for Triple-Negative Breast Cancer: An Exploratory Clinical Study on Mechanisms and Efficacy
ACTIVE_NOT_RECRUITINGupdated 20d ago
community read0 votes
Sponsor: Harbin Medical University. Phase: PHASE2. Conditions: Breast Cancer Triple Negative Breast Cancer
view source ↗
comments(0)
5-min edit window · permanent after that